Abstract:Objective The purpose of this study was to assess the relationship between MRI findings and clinical presentation and outcomes in patients following mild traumatic brain injury (mTBI). We hypothesize that imaging findings other than hemorrhages and contusions may be used to predict symptom presentation and longevity following mTBI. Methods Patients (n = 250) diagnosed with mTBI and in litigation for brain injury underwent 3T magnetic resonance imaging (MRI). A retrospective chart review was performed to assess… Show more
“…The duration of LOC in women, but not men, was positively correlated with loss of balance, poor coordination, fatigue, and overall vestibular impairment score on the NSI in a study comparing male and female veterans [22]. Additionally, LOC was associated with balance problems, fatigue, and headache; interestingly, every patient with LOC in this study reported headache [25]. In military personnel, LOC was associated with greater levels of plasma interleukin (IL)-6, a pro-inflammatory cytokine, and greater self-reported pain levels [20].…”
Section: Physical Symptomsmentioning
confidence: 52%
“…The presence and duration of LOC are associated with cognitive deficits after mTBI. LOC was associated with cognitive deficits and slow recovery of cognitive function [25]. Among military personnel and civilian contractors, longer duration of LOC was associated with a greater decline in accuracy on the Automated Neuropsychological Assessment Metric (ANAM), which measures reaction time, learning, and memory, between baseline and post-injury tests [11].…”
Section: Cognitive and Memory Deficitsmentioning
confidence: 99%
“…LOC after mTBI is associated with the development of psychiatric disorders, including post-traumatic stress disorder (PTSD) and major depressive disorder (MDD). One study reported that LOC was associated with MDD and emotional lability, a condition characterized by exaggerated and rapidly fluctuating emotions [25]. Among patients stratified by age, sex, and LOC status, LOC was associated with development of anxiety, suicidal ideation, and MDD within a 180-day period after admission for mTBI [27].…”
Identifying predictors for individuals vulnerable to the adverse effects of traumatic brain injury (TBI) remains an ongoing research pursuit. This is especially important for patients with mild TBI (mTBI), whose condition is often overlooked. TBI severity in humans is determined by several criteria, including the duration of loss of consciousness (LOC): LOC < 30 min for mTBI and LOC > 30 min for moderate-to-severe TBI. However, in experimental TBI models, there is no standard guideline for assessing the severity of TBI. One commonly used metric is the loss of righting reflex (LRR), a rodent analogue of LOC. However, LRR is highly variable across studies and rodents, making strict numeric cutoffs difficult to define. Instead, LRR may best be used as predictor of symptom development and severity. This review summarizes the current knowledge on the associations between LOC and outcomes after mTBI in humans and between LRR and outcomes after experimental TBI in rodents. In clinical literature, LOC following mTBI is associated with various adverse outcome measures, such as cognitive and memory deficits; psychiatric disorders; physical symptoms; and brain abnormalities associated with the aforementioned impairments. In preclinical studies, longer LRR following TBI is associated with greater motor and sensorimotor impairments; cognitive and memory impairments; peripheral and neuropathology; and physiologic abnormalities. Because of the similarities in associations, LRR in experimental TBI models may serve as a useful proxy for LOC to contribute to the ongoing development of evidence-based personalized treatment strategies for patients sustaining head trauma. Analysis of highly symptomatic rodents may shed light on the biological underpinnings of symptom development after rodent TBI, which may translate to therapeutic targets for mTBI in humans.
“…The duration of LOC in women, but not men, was positively correlated with loss of balance, poor coordination, fatigue, and overall vestibular impairment score on the NSI in a study comparing male and female veterans [22]. Additionally, LOC was associated with balance problems, fatigue, and headache; interestingly, every patient with LOC in this study reported headache [25]. In military personnel, LOC was associated with greater levels of plasma interleukin (IL)-6, a pro-inflammatory cytokine, and greater self-reported pain levels [20].…”
Section: Physical Symptomsmentioning
confidence: 52%
“…The presence and duration of LOC are associated with cognitive deficits after mTBI. LOC was associated with cognitive deficits and slow recovery of cognitive function [25]. Among military personnel and civilian contractors, longer duration of LOC was associated with a greater decline in accuracy on the Automated Neuropsychological Assessment Metric (ANAM), which measures reaction time, learning, and memory, between baseline and post-injury tests [11].…”
Section: Cognitive and Memory Deficitsmentioning
confidence: 99%
“…LOC after mTBI is associated with the development of psychiatric disorders, including post-traumatic stress disorder (PTSD) and major depressive disorder (MDD). One study reported that LOC was associated with MDD and emotional lability, a condition characterized by exaggerated and rapidly fluctuating emotions [25]. Among patients stratified by age, sex, and LOC status, LOC was associated with development of anxiety, suicidal ideation, and MDD within a 180-day period after admission for mTBI [27].…”
Identifying predictors for individuals vulnerable to the adverse effects of traumatic brain injury (TBI) remains an ongoing research pursuit. This is especially important for patients with mild TBI (mTBI), whose condition is often overlooked. TBI severity in humans is determined by several criteria, including the duration of loss of consciousness (LOC): LOC < 30 min for mTBI and LOC > 30 min for moderate-to-severe TBI. However, in experimental TBI models, there is no standard guideline for assessing the severity of TBI. One commonly used metric is the loss of righting reflex (LRR), a rodent analogue of LOC. However, LRR is highly variable across studies and rodents, making strict numeric cutoffs difficult to define. Instead, LRR may best be used as predictor of symptom development and severity. This review summarizes the current knowledge on the associations between LOC and outcomes after mTBI in humans and between LRR and outcomes after experimental TBI in rodents. In clinical literature, LOC following mTBI is associated with various adverse outcome measures, such as cognitive and memory deficits; psychiatric disorders; physical symptoms; and brain abnormalities associated with the aforementioned impairments. In preclinical studies, longer LRR following TBI is associated with greater motor and sensorimotor impairments; cognitive and memory impairments; peripheral and neuropathology; and physiologic abnormalities. Because of the similarities in associations, LRR in experimental TBI models may serve as a useful proxy for LOC to contribute to the ongoing development of evidence-based personalized treatment strategies for patients sustaining head trauma. Analysis of highly symptomatic rodents may shed light on the biological underpinnings of symptom development after rodent TBI, which may translate to therapeutic targets for mTBI in humans.
“…Brain volume abnormalities correlated with acute measures of injury (including greater duration of posttraumatic amnesia and lower GCS score) and presence of diffuse axonal injury (Brezova et al, 2014). Vanier et al (Vanier et al, 2020) divided a sample of mild TBI patients into those with and without MRI brain abnormalities, including hippocampal atrophy or asymmetry based on NeuroQuant R analyses; patients with MRI abnormalities had slower recovery from balance and cognitive deficits. In a study of pediatric patients with TBI, Wright et al found that increased volumes of white matter hyperintensities measured by NeuroQuant R correlated with decreased cognitive processing speed (Wright et al, 2020).…”
Over 40 years of research have shown that traumatic brain injury affects brain volume. However, technical and practical limitations made it difficult to detect brain volume abnormalities in patients suffering from chronic effects of mild or moderate traumatic brain injury. This situation improved in 2006 with the FDA clearance of NeuroQuant®, a commercially available, computer-automated software program for measuring MRI brain volume in human subjects. More recent strides were made with the introduction of NeuroGage®, commercially available software that is based on NeuroQuant® and extends its utility in several ways. Studies using these and similar methods have found that most patients with chronic mild or moderate traumatic brain injury have brain volume abnormalities, and several of these studies found—surprisingly—more abnormal enlargement than atrophy. More generally, 102 peer-reviewed studies have supported the reliability and validity of NeuroQuant® and NeuroGage®. Furthermore, this updated version of a previous review addresses whether NeuroQuant® and NeuroGage® meet the Daubert standard for admissibility in court. It concludes that NeuroQuant® and NeuroGage® meet the Daubert standard based on their reliability, validity, and objectivity. Due to the improvements in technology over the years, these brain volumetric techniques are practical and readily available for clinical or forensic use, and thus they are important tools for detecting signs of brain injury.
“…These include multiple studies that found that NeuroQuant V R is reliable for measuring brain volume in normal subjects, patients with TBI, and other neuropsychiatric patients 8,[29][30][31][32][33][34][35] and valid for assessing brain volume in patients with TBI. 4,5,8,12,16,19,25,33,[35][36][37][38][39][40][41] Neuroquant V R automated brain MRI segmentation. The brain MRI grayscale images for each patient and NeuroGage V R normal control V R were uploaded to the NeuroQuant V R server, which processed and analyzed the brain imaging data.…”
Section: Brain Imaging and Volume Measurementmentioning
Introduction Many studies have found brain atrophy in patients with traumatic brain injury (TBI), but most of those studies examined patients with moderate or severe TBI. A few recent studies in patients with chronic mild or moderate TBI found abnormally large brain volume. Some of these studies used NeuroQuant®, FDA-cleared software for measuring MRI brain volume. It is not known if the abnormal enlargement occurs before or after injury. The purpose of the current study was to test the hypothesis that it occurs after injury. Methods 55 patients with chronic mild or moderate TBI were compared to NeuroQuant® normal controls ( n > 4000) with respect to MRI brain volume change from before injury (time 0 [t0], estimated volume) to after injury (t1, measured volume). A subset of 36 patients were compared to the normal controls with respect to longitudinal change of brain volume after injury from t1 to t2. Results The patients had abnormally fast increase of brain volume for multiple brain regions, including whole brain, cerebral cortical gray matter, and subcortical regions. Discussion This is the first report of extensive abnormal longitudinal brain volume enlargement in patients with TBI. In particular, the findings suggested that the previously reported findings of cross-sectional brain volume abnormal enlargement were due to longitudinal enlargement after, not before, injury. Abnormal longitudinal enlargement of the posterior cingulate cortex correlated with neuropathic headaches, partially replicating a previously reported finding that was associated with neuroinflammation.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.